ANDREW ROSENZWEIG: Open Payments
NPI 1942203690 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$75,907 in 93 payments from 3 companies in 2025. Trend: 2023 $59,342 · 2024 $90,949 · 2025 $75,907
Speaker / faculty: $59,971Consulting: $7,125Travel & lodging: $6,459Food & beverage: $2,353
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 53 | $40,183 |
| Neurocrine BioSciences, Inc. | 32 | $26,966 |
| ACADIA Pharmaceuticals Inc | 8 | $8,758 |
Products named: REXULTI, INGREZZA, NUPLAZID.
Industry payments across RI — which companies pay providers there.
